{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:17:00Z","timestamp":1789060620753,"version":"build-2803163510"},"reference-count":24,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.3892\/or.2013.2538","type":"journal-article","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T12:14:12Z","timestamp":1370952852000},"page":"695-700","source":"Crossref","is-referenced-by-count":13,"title":["High-risk HPV L1 capsid protein as a marker of cervical intraepithelial neoplasia in high-risk HPV-positive women with minor cytological abnormalities"],"prefix":"10.3892","volume":"30","author":[{"given":"INGRID","family":"NORMAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDERS","family":"HJERPE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SONIA","family":"ANDERSSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,6,11]]},"reference":[{"key":"key20180107223658_b1-or-30-02-0695","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjc.6690666","article-title":"Trends in cancer of the cervix uteri in Sweden following cytological screening","volume":"81","author":"Bergstrom","year":"1999","journal-title":"Br J Cancer"},{"key":"key20180107223658_b2-or-30-02-0695","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1158\/1055-9965.EPI-07-0278","article-title":"A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment","volume":"16","author":"Gunnell","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107223658_b3-or-30-02-0695","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(98)12490-X","article-title":"Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study","volume":"354","author":"Nobbenhuis","year":"1999","journal-title":"Lancet"},{"key":"key20180107223658_b4-or-30-02-0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6532(00)00125-6","article-title":"Human papillomavirus and cancer: the epidemiological evidence","volume":"19","author":"Mu\u00f1oz","year":"2000","journal-title":"J Clin Virol"},{"key":"key20180107223658_b5-or-30-02-0695","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"key20180107223658_b6-or-30-02-0695","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"key20180107223658_b7-or-30-02-0695","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0168-1702(02)00187-9","article-title":"The viral etiology of cervical cancer","volume":"89","author":"Bosch","year":"2002","journal-title":"Virus Res"},{"key":"key20180107223658_b8-or-30-02-0695","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107223658_b9-or-30-02-0695","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"key":"key20180107223658_b10-or-30-02-0695","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/171.4.1026","article-title":"Human papillomavirus infection is transient in young women: a population-based cohort study","volume":"171","author":"Evander","year":"1995","journal-title":"J Infect Dis"},{"key":"key20180107223658_b11-or-30-02-0695","first-page":"23","article-title":"Human papillomavirus in the immunosuppressed","volume":"3","author":"Benton","year":"1992","journal-title":"Papillomavirus Rep"},{"issue":"Suppl 1","key":"key20180107223658_b12-or-30-02-0695","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.vaccine.2005.09.002","article-title":"Immune responses to human papillomavirus","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"key":"key20180107223658_b13-or-30-02-0695","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2007.11.006","article-title":"Interferon-\u03b3 (IFN-\u03b3): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV)","volume":"108","author":"Song","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20180107223658_b14-or-30-02-0695","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ajcp\/102.6.768","article-title":"Immunological events in regressing genital warts","volume":"102","author":"Coleman","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"key20180107223658_b15-or-30-02-0695","first-page":"483","article-title":"Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide","volume":"11","author":"Kadish","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20180107223658_b16-or-30-02-0695","first-page":"241","article-title":"Correlation of immunochemical detection of HPV L1 capsid protein in pap smears with regression of high-risk HPV positive mild\/moderate dysplasia","volume":"26","author":"Griesser","year":"2004","journal-title":"Anal Quant Cytol Histol"},{"key":"key20180107223658_b17-or-30-02-0695","first-page":"78","article-title":"Prognostic relevance of human papillomavirus L1 capsid protein detection within mild and moderate dysplastic lesions of the cervix uteri in combination with p16 biomarker","volume":"30","author":"Hilfrich","year":"2008","journal-title":"Anal Quant Cytol Histol"},{"key":"key20180107223658_b18-or-30-02-0695","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"key20180107223658_b19-or-30-02-0695","first-page":"301","article-title":"Cervical intraepithelial neoplasia","volume":"8","author":"Richart","year":"1973","journal-title":"Pathol Annu"},{"key":"key20180107223658_b20-or-30-02-0695","doi-asserted-by":"crossref","first-page":"17.e1","DOI":"10.1016\/j.ajog.2009.01.005","article-title":"Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping","volume":"201","author":"Brismar","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"key20180107223658_b21-or-30-02-0695","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000326491","article-title":"Immunocytochemical detection of HPV high-risk type L1 capsid proteins in LSIL and HSIL as compared with detection of HPV L1 DNA","volume":"47","author":"Melsheimer","year":"2003","journal-title":"Acta Cytol"},{"key":"key20180107223658_b22-or-30-02-0695","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1309\/AJCPCU0HBFFFGDTV","article-title":"HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions","volume":"132","author":"Griesser","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key20180107223658_b23-or-30-02-0695","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<818::AID-IJC4>3.0.CO;2-T","article-title":"No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6\/11","volume":"80","author":"Luostarinen","year":"1999","journal-title":"Int J Cancer"},{"key":"key20180107223658_b24-or-30-02-0695","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2538\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T22:46:52Z","timestamp":1515365212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,11]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,6,11]]},"published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.3892\/or.2013.2538"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2538","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,11]]}}}